Literature DB >> 7699453

SPECT diagnosis of Creutzfeld-Jacob disease.

J Aharon-Peretz1, A Peretz, J A Hemli, S Honigman, O Israel.   

Abstract

SPECT with 99mTc-HMPAO was performed on a 65-yr-old patient with Creutzfeld-Jacob disease. Cerebral blood flow was heterogeneously decreased throughout the brain, differing from the pattern observed in other common types of dementia. These results suggest that HMPAO-SPECT may provide useful information in the differential diagnosis of dementia, specifically when Creutzfeld-Jacob disease is suspected.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7699453

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  1 in total

1.  18F-fluorodeoxyglucose-PET and 99mTc-bicisate-SPECT in Creutzfeldt-Jakob disease.

Authors:  F Grünwald; C Pohl; H Bender; A Hartmann; C Menzel; J Ruhlmann; E Keller; H J Biersack
Journal:  Ann Nucl Med       Date:  1996-02       Impact factor: 2.668

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.